Après des années de travail de développement continu, Basel Area Business & Innovation vient de lancer InnoJura, un nouveau programme conçu pour rassembler les startups et les PME de la région du Jura ...

In the second half of 2025 five medtech and digital health startups obtained the Innosuisse Certificate, a readiness label for startups positioned for sustainable growth. Their products range from ...

Für die Fintech Week erfinden die Organisatoren das Rad nicht neu, sondern integrieren bewährte Formate. Zwischen 19. und 25. Juni werden das FuW „FinTech“ Forum, die Swiss FinTech Awards, die SFTA ...

Completed on December 19, 2025, the EASA-supervised campaign places Valais headquartered H55 at the forefront of efforts to establish certification-grade, aviation-safe propulsion battery systems, ...

Athens-based VC firms Big Pi Ventures and Evercurious VC have invested $4.5M in ORamaVR, the startup pioneering Computational Medical Extended Reality platform. With their solutions being used by ...

Swiss Startup Radar 8: Focus on growth The eightth edition investigates the often-cited weak growth of the Swiss start-up ecosystem. It reveals which group of start-ups plays a decisive role in terms ...

The funding will be used to accelerate the commercial rollout of Jua’s Earth Intelligence Platform, a decision engine that helps energy traders make faster, more profitable decisions by simulating how ...

According to the recently published report by Dealroom, the European deep tech sector is on a healthy growth trajectory. In recent years, the deep tech sector has proven to be a resilient sector that ...

Configure your own data insights with our huge database of swiss startups.

Based on the breakthrough research in kidney medicine by Prof. Dr Andreas Pasch, Calciscon developed the T50 Calcification Propensity test, the first blood test to assess the ageing of the vascular ...

Basel-based startup Allegria has closed a USD 3.5 million seed financing round led by Forty51 Ventures to advance the research and development of its therapeutics for mast cell-mediated diseases. This ...

Transmutex SA, a nuclear engineering startup based in Geneva, announces a new round of financing to further develop its solution for a safer, lower-cost, proliferation-resistant nuclear energy ...